(P-1186) Pharmacodynamic Assessment of Combination of Cefiderocol with Xeruborbactam in Murine Thigh Infection Model

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

MI

Masaaki Izawa, Researcher

Shionogi & Co., Ltd.
Toyonaka-shi, Osaka, Japan
SK

Sachi Kanazawa, PhD

Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan
TH

Takafumi Hara, MSc (he/him/his)

Researcher
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan
DG

David Griffith, n/a

Sr. Vice-President, Non-Clinical and Clinical Development
Qpex Biopharma
San Diego, California, United States
Yoshinori Yamano, PhD (he/him/his)

Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan